Authors: | Watts, J. M.; Wang, X. V.; Litzow, M. R.; Luger, S. M.; Lazarus, H. M.; Cassileth, P. A.; Fernandez, H. F.; Douer, D.; Zickl, L.; Paietta, E.; Rowe, J. M.; Tallman, M. S. |
Article Title: | Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients |
Abstract: | We examined 1229 younger patients with acute myeloid leukemia who achieved CR1 on Eastern Cooperative Oncology Group trials. We defined late relapse as occurring after ≥3 years of CR1. With median follow-up of 11.3 years, there were 14 late relapses (1.1% of CR1 patients; 3.3% of 3-year CR1 patients). Eight achieved second CR and median overall survival after late relapse was 3.2 years. Most patients tested (9/11) had a normal karyotype at diagnosis; none had new cytogenetic abnormalities at relapse. Late relapse is rare and nearly all 3-year CR1 patients are cured. If late relapse occurs, outcomes are relatively favorable. © 2014 Elsevier Ltd. |
Keywords: | adolescent; adult; cancer survival; controlled study; middle aged; young adult; acute granulocytic leukemia; major clinical study; overall survival; follow up; cytogenetics; cancer mortality; high risk patient; leukocyte count; leukemia relapse; health care organization; karyotype; outcomes; clinical trials; leukemia remission; acute myeloid leukemia; late relapse; normal cytogenetics; human; male; female; priority journal; article; eastern cooperative oncology group |
Journal Title: | Leukemia Research |
Volume: | 38 |
Issue: | 8 |
ISSN: | 0145-2126 |
Publisher: | Elsevier Ltd |
Date Published: | 2014-08-01 |
Start Page: | 901 |
End Page: | 906 |
Language: | English |
DOI: | 10.1016/j.leukres.2014.05.018 |
PROVIDER: | scopus |
PUBMED: | 24986381 |
PMCID: | PMC4326112 |
DOI/URL: | |
Notes: | Export Date: 2 September 2014 -- CODEN: LERED -- Source: Scopus |